Clinical results for Wegovy The STEP 1 study looked at how Wegovy works in people with a BMI of 27 or higher
Potential benefits include improved muscle mass, better recovery, enhanced sleep, and overall vitality, making them attractive to certain individuals seeking a boost in quality of life or athletic performance
References Glucagon-like peptide-1 receptor agonists and peripheral neuropathy: A systematic review Triple agonist peptides and neurological complications in clinical trials Mechanisms of drug-induced allodynia in metabolic therapies B vitamin supplementation in peripheral neuropathy management Lipotropic compounds and neurological recovery mechanisms
T2DM, a chronic and widespread worldwide disease, is characterized by insulin resistance, hyperglycemia, oxidative stress, neuroinflammation, and cerebrovascular dysfunction, factors that collectively contribute to cognitive decline